Business Description
Tango Therapeutics Inc
NAICS : 325412
SIC : 2834
Description
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 8.06 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.18 | |||||
| Debt-to-EBITDA | -0.36 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | 0.01 | |||||
| Beneish M-Score | -4.07 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 68.11 | |||||
| 9-Day RSI | 57.24 | |||||
| 14-Day RSI | 52.4 | |||||
| 6-1 Month Momentum % | -54.21 | |||||
| 12-1 Month Momentum % | -42.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.39 | |||||
| Quick Ratio | 6.39 | |||||
| Cash Ratio | 6.22 | |||||
| Days Sales Outstanding | 29.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -466.37 | |||||
| Net Margin % | -446.26 | |||||
| ROE % | -40.54 | |||||
| ROA % | -24.95 | |||||
| ROIC % | -157.48 | |||||
| ROC (Joel Greenblatt) % | -304.46 | |||||
| ROCE % | -29.29 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 12.94 | |||||
| PB Ratio | 1.42 | |||||
| Price-to-Tangible-Book | 1.42 | |||||
| EV-to-EBIT | -0.14 | |||||
| EV-to-Forward-EBIT | -1.15 | |||||
| EV-to-EBITDA | -0.14 | |||||
| EV-to-Revenue | 0.64 | |||||
| EV-to-Forward-Revenue | 0.9 | |||||
| EV-to-FCF | -0.07 | |||||
| Price-to-Net-Current-Asset-Value | 1.94 | |||||
| Price-to-Net-Cash | 2.06 | |||||
| Earnings Yield (Greenblatt) % | -714.29 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:TNGX
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Annualized Return %
Total Annual Return %
Tango Therapeutics Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 24.868 | ||
| EPS (TTM) ($) | -1.26 | ||
| Beta | 0 | ||
| Volatility % | 139.7 | ||
| 14-Day RSI | 52.4 | ||
| 14-Day ATR ($) | 0.367826 | ||
| 20-Day SMA ($) | 3.444 | ||
| 12-1 Month Momentum % | -42.74 | ||
| 52-Week Range ($) | 2.47 - 8.5581 | ||
| Shares Outstanding (Mil) | 88.41 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tango Therapeutics Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tango Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tango Therapeutics Inc Frequently Asked Questions
What is Tango Therapeutics Inc(TNGX)'s stock price today?
The current price of TNGX is $3.67. The 52 week high of TNGX is $8.56 and 52 week low is $2.47.
When is next earnings date of Tango Therapeutics Inc(TNGX)?
The next earnings date of Tango Therapeutics Inc(TNGX) is 2023-08-10 Est..
Does Tango Therapeutics Inc(TNGX) pay dividends? If so, how much?
Tango Therapeutics Inc(TNGX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers